CellSource Co., Ltd.

2026/11/11 19:41 Updated
Market Cap: $35.2M (¥5.6B)
Stock Price: $1.77 (¥281)
Exchange Rate: 1 USD = ¥158.48

November 11, 2026 Flash Report: Monthly KPI for October Fiscal Year 2026

The average number of processed orders received per day in October was 50.5. The report discloses month-over-month and year-over-year trends, changes by clinical department (self-pay specialized orthopedics, hybrid orthopedics, obstetrics and gynecology, and aesthetics). It also reports changes in order counts by group and explains the impact of the new KPI introduced this fiscal year.

Importance:
Page Updated: November 11, 2026
IR Disclosure Date: November 11, 2026

Key Figures

  • Average number of processed orders received per day: 50.5 shares
  • Number of blood-derived processing orders for self-pay specialized orthopedics: 561 shares (Year-over-year -29.7%)
  • Number of blood-derived processing orders for hybrid orthopedics: 773 shares (Year-over-year -27.3%)

AI要約

Performance and KPI Overview

CellSource Co., Ltd. announced the monthly KPI flash report for October of the fiscal year ending October 2026. The average number of processed orders received per day was 50.5, a year-over-year decrease. By clinical department, orders for self-pay specialized orthopedics and hybrid orthopedics both decreased year-over-year, while orders for obstetrics and gynecology and for aesthetics increased. By group, Group 1 saw a decline in orders, whereas Group 2 experienced a significant increase, reflecting the contribution of this fiscal year's KPI renewal.

Business Trends and Outlook

Group 1 aims for steady foundational improvement, while Group 2 pursues order growth through support for launching new partner clinics and promoting utilization. Total orders in October increased compared with the same period last year, aided by this fiscal year's KPI renewal. Going forward, the company plans to expand its order base via development of business support services for medical institutions and clearer role allocation among groups.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

CellSource Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →